Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study

STUDY QUESTION: Does the GnRH antagonist, ASP1707, reduce endometriosis-associated pelvic pain? SUMMARY ANSWER: ASP1707 significantly reduced endometriosis-associated pelvic pain in a dose-related manner WHAT IS KNOWN ALREADY: GnRH agonists are an effective therapeutic option for endometriosis that...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Hooghe, Thomas, Fukaya, Takao, Osuga, Yutaka, Besuyen, Robin, López, Beatriz, Holtkamp, Gertjan M, Miyazaki, Kentaro, Skillern, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505452/
https://www.ncbi.nlm.nih.gov/pubmed/31067329
http://dx.doi.org/10.1093/humrep/dez028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505452/
https://www.ncbi.nlm.nih.gov/pubmed/31067329
http://dx.doi.org/10.1093/humrep/dez028

Ejemplares similares